Fibrotic Fingerprints: Shared Signatures across Autoimmune Diseases
Date and Time
– December 10, 2026, 5:00 PM ESTThe OADR-ORWH ScienceTALKS series aims to convene experts in the field to examine the state of the science in specific areas impacting autoimmune disease research.
Dr. Carol Feghali-Bostwick, SmartState and Kitty Trask Holt Endowed Chair for Scleroderma Research and Distinguished University Professor of Medicine at the Medical University of South Carolina, Charleston, guest speaker for this edition of ScienceTALKS, will focus on scleroderma and other fibrotic diseases. She will delve into the science of fibrosis and her work exploring mechanisms of fibrosis across autoimmune and rare diseases. ScienceTALKS is designed for a scientific audience with an interest in autoimmune disease research. The events are open to the public, but scientific talks may not be tailored for a general audience.
Sign language interpreting services are available upon request. Individuals who need interpreting services and/or other reasonable accommodations to participate in this event should email [email protected]. Requests should be made at least five business days in advance of the event.
Image
| Carol Feghali-Bostwick, PhD Dr. Carol Feghali-Bostwick is a Distinguished Professor in the Department of Medicine at the Medical University of South Carolina and the Kitty Trask Holt and SmartState Endowed Chair for Scleroderma Research. Dr. Feghali-Bostwick’s research has focused on mechanisms mediating the development and resolution of fibrosis in disorders such as Systemic Sclerosis (SSc) and Idiopathic Pulmonary Fibrosis (IPF). Her research has resulted in the identification of novel pro- fibrotic and anti-fibrotic factors. Her research team led the initial gene expression profiling of SSc lung tissues, identified novel autoantibodies associated with SSc-associated interstitial lung disease, and contributed to a better understanding of fibroblast biology in dermal and pulmonary fibrosis. She conducted the only study of twins with SSc, which led to the observation that the disease is likely multifactorial with environmental factors playing an important role in the development of the SSc phenotype. Dr. Feghali-Bostwick has authored and co-authored over 180 original manuscripts and holds several patents. In addition to research, Dr. Feghali-Bostwick is actively engaged in mentoring junior investigators. She established a national Early Career Investigator mentoring program for investigators focusing on scleroderma-related research as well as a national entrepreneurship training and coaching program. Dr. Feghali-Bostwick is a fellow of the National Academy of Inventors. She also currently serves as the Chair of the Board of Directors of the National Scleroderma Foundation. Registration link: ScienceTALKS - Fibrotic Fingerprints: Shared Signatures across Autoimmune Diseases |